Kerget, B. Et Al. 2023. Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study. MEDICINA CLINICA , vol.160, no.12 , 525-530.

Kerget, B., Çil, G., Araz, Ö., Alper, F., & Akgün, M., (2023). Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study. MEDICINA CLINICA , vol.160, no.12, 525-530.

Kerget, Buğra Et Al. "Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study," MEDICINA CLINICA , vol.160, no.12, 525-530, 2023

Kerget, Buğra Et Al. "Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study." MEDICINA CLINICA , vol.160, no.12, pp.525-530, 2023

Kerget, B. Et Al. (2023) . "Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study." MEDICINA CLINICA , vol.160, no.12, pp.525-530.

@article{article, author={Buğra KERGET Et Al. }, title={Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study}, journal={MEDICINA CLINICA}, year=2023, pages={525-530} }